F

Ferring Pharmaceuticals

Develops peptide hormone-based medicines and therapies

Accounting & Reporting Specialist

Financial AccountingPosted on Nov 9
Full-timeLisbon, PortugalNo salary listedIn-person

About the Job

Requirements

  • A bachelor's or master's degree in Business Administration, Corporate Finance, Accounting, or a related field.
  • Four to six years of relevant work experience as an Accounting and Reporting Specialist.
  • Solid analytical capacity and understanding of financial and accounting principles and processes.
  • Ability to work in a matrix organization and demonstrate communication and stakeholder-management skills.
  • Business acumen, problem-solving, customer focus, and collaboration skills.
  • Proficiency or fluency in English is mandatory.

Responsibilities

  • Own accounting and reporting activities across European markets.
  • Work with internal stakeholders and external partners in an international environment.
  • Review financial statements and perform account reconciliations to ensure accuracy and quality of financial information.
  • Support month-end and year-end closing activities and timely financial reporting.
  • Ensure tax and regulatory compliance and maintain effective internal controls.
  • Support internal and external audits.
  • Analyze financial data, investigate discrepancies, and identify opportunities to improve processes and controls.
  • Own projects beyond day-to-day accounting activities.
  • Contribute ideas, challenge existing ways of working, and help improve Finance processes.
  • Contribute to continuous improvement and the ongoing development of the Finance CoE.

Desired Qualifications

  • Experience working with SAP Fiori.

About the Company

Ferring Pharmaceuticals

Develops peptide hormone-based medicines and therapies

Ferring Pharmaceuticals develops medicines that use the body's own peptide hormones, focusing on specialties such as reproductive health, gastroenterology, and urology. Its products range from hormone-based therapies to newer gene-based treatments, such as Adstiladrin for bladder cancer. The company achieves its solutions through research-driven development and manufacturing, including synthetic production of peptide hormones (historically oxytocin and vasopressin) and ongoing expansion of production and clinical programs. Ferring differentiates itself by remaining privately held to pursue a long-term research vision, growing through organic expansion and strategic acquisitions while maintaining a global footprint (over 100 countries, 7,000+ employees). Its goal is to advance therapies that leverage the body's biology to treat diseases more effectively, supported by a sustained investment in R&D and manufacturing, with a future focus on bioengineered and gene-based approaches.

Company size
5,001-10,000
Company stage
Debt Financing
Total funding
$302.5M
Headquarters
Saint-Prex, Switzerland
Founded
1950

Recently Posted Jobs

Explore more opportunities at Ferring Pharmaceuticals

See more jobs